Page last updated: 2024-10-29

ifosfamide and Prostatic Neoplasms

ifosfamide has been researched along with Prostatic Neoplasms in 47 studies

Prostatic Neoplasms: Tumors or cancer of the PROSTATE.

Research Excerpts

ExcerptRelevanceReference
" We report a patient who improved following intra-arterial infusion of cisplatin (CDDP) and ifosfamide (IFM) to treat urinary retention caused by locally recurring HRPC."7.78Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide. ( Hayashi, T; Matsuoka, K; Nishihara, K; Tomiyasu, K; Uemura, K, 2012)
"Nineteen patients with hormonal refractory adenocarcinoma of the prostate were treated with ifosfamide (IFM) and the combination of vincristine, ifosfamide and peplomycin (VIP)."7.67[Treatment of hormonal refractory adenocarcinoma of the prostate with ifosfamide (IFM) and the combination of vincristine ifosfamide and peplomycin (VIP)]. ( Ebisui, K; Fujiwara, M; Kobayashi, T; Miyakoda, K; Nakagawa, S; Nakao, M; Nukui, M; Takada, H; Toyoda, K; Watanabe, H, 1989)
"Ifosfamide (Z 4942) is an alkylating agent with the structure of a cyclophosphamide analog."5.27[Treatment of pain caused by metastases of reactivated prostatic cancer with ifosfamide]. ( Kawai, T; Kihara, K; Sakuramoto, T; Satomi, Y; Takeda, T, 1983)
" We report a patient who improved following intra-arterial infusion of cisplatin (CDDP) and ifosfamide (IFM) to treat urinary retention caused by locally recurring HRPC."3.78Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide. ( Hayashi, T; Matsuoka, K; Nishihara, K; Tomiyasu, K; Uemura, K, 2012)
"Eleven patients with advanced adenocarcinoma of the prostate were treated with a cyclic alternating chemotherapy (VIP-DMF therapy), consisting of a three-drug combination of vincristine, ifosfamide, and peplomycin; and a three-drug combination of adriamycin, mitomycin C and 5-fluorouracil."3.67[Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate]. ( Akagi, T; Hara, M; Nanba, K; Obama, T; Ochi, J; Ozaki, Y; Saegusa, M; Tanahashi, T; Tsushima, T; Yoshimoto, J, 1987)
"Nineteen patients with hormonal refractory adenocarcinoma of the prostate were treated with ifosfamide (IFM) and the combination of vincristine, ifosfamide and peplomycin (VIP)."3.67[Treatment of hormonal refractory adenocarcinoma of the prostate with ifosfamide (IFM) and the combination of vincristine ifosfamide and peplomycin (VIP)]. ( Ebisui, K; Fujiwara, M; Kobayashi, T; Miyakoda, K; Nakagawa, S; Nakao, M; Nukui, M; Takada, H; Toyoda, K; Watanabe, H, 1989)
"Twelve patients with stage D2 adenocarcinoma of the prostate were treated with the combination chemotherapy of ifosfamide (2 g/body, i."3.67[Combination chemotherapy with ifosfamide, 5-fluorouracil, cisplatin for stage D2 prostatic cancer]. ( Andoh, M; Fukui, I; Higashi, Y; Horiuchi, S; Kihara, K; Kitahara, S; Oshima, H; Takeuchi, S, 1989)
" The optimal sequence of chemotherapeutic agents was investigated by reversing the order of administration in the second cycle and by collecting a total of six pharmacokinetic blood samples per cycle from all patients during the first and second cycles."2.71Docetaxel-ifosfamide combination chemotherapy in patients with metastatic hormone-refractory prostate cancer: a phase I pharmacokinetic study. ( Hervonen, P; Jekunen, A; Kellokumpu-Lehtinen, P; Lefebvre, P, 2003)
"The ongoing phase I study reported here sought to determine the maximum tolerated doses of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) and carboplatin when given at specific times in combination with ifosfamide, mesna, and filgrastim."2.68Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results. ( Palackdharry, CS, 1997)
"Prostate cancer, bladder cancer, renal cancer and testicular cancer are common among urological cancers."2.41[Chemotherapy and radiotherapy for urological cancer]. ( Akaza, H; Hattori, K; Kawai, K; Miyanaga, N; Shimazui, T; Tsukamoto, S; Uchida, K, 2002)
"Patients with hormone-unresponsive prostate cancer were scheduled to receive CDDP 70 mg/m2 intravenously on day 1 and IFM 1."2.40[Combination chemotherapy with cis-platinum and ifosfamide for hormone unresponsive prostate cancer]. ( Asahi, T; Hata, K; Katayama, Y; Kobashi, K; Kobuke, M; Kondo, K; Kumon, H; Maki, Y; Nanba, K; Nasu, Y; Ochi, J; Ohashi, T; Ohmori, H; Ozaki, Y; Saegusa, M; Saika, T; Tanahashi, T; Tsushima, T; Uno, S; Yamashita, Y, 1998)
"The spindle cell rhabdomyosarcoma is a rare variant of the embryonal rhabdomyosarcoma, mostly occurring in childhood."1.39Spindle cell rhabdomyosarcoma of the prostate. ( Ellinger, J; Fechner, G; Goltz, D; Latz, S; Leuschner, I; Marx, C; Müller, SC, 2013)
"The patient died due to brain metastases 20 months after the start of intra-arterial chemotherapy."1.30[A case of metastatic liver tumors from prostatic cancer responding to intra-arterial infusion chemotherapy with CDDP and ifosfamide using implantable port]. ( Hasegawa, N; Kazama, A; Kondo, N; Tomita, M, 1999)
"The patients with prostatic cancer were treated with VIP (vincristine, ifosfamide, peplomycin) chemotherapy and the patients with urothelial cancer were treated with MP (methotrexate, cisplatinum) or MEP (methotrexate, Etoposide, cisplatinum) combination chemotherapy."1.29[Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer]. ( Kitamura, Y; Komatsubara, S; Sakata, Y; Watanabe, M, 1993)
" After dosing with the D-compound, the highest levels of radioactivity were found in the liver, kidneys, thymus, thyroid gland, and central nervous system, including the brain."1.29Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat. ( Bertram, B; Bollow, U; Hull, WE; Pohl, J; Port, R; Schaper, M; Stüben, J; Wiessler, M, 1996)
"Ifosfamide (Z 4942) is an alkylating agent with the structure of a cyclophosphamide analog."1.27[Treatment of pain caused by metastases of reactivated prostatic cancer with ifosfamide]. ( Kawai, T; Kihara, K; Sakuramoto, T; Satomi, Y; Takeda, T, 1983)
"Treatment with ifosfamide or combination chemotherapy with vincristine, ifosfamide and peplomycin was performed in some of the 65 cases above mentioned."1.27[Reactivation of prostatic cancer and chemotherapy in reactivated prostatic cancer]. ( Ando, K; Fuse, H; Hara, S; Shimazaki, J; Zama, S, 1985)
"Ten patients with reactivated stage D prostatic cancer were treated with the combination therapy of vincristine, ifosfamide and peplomycin (VIP therapy)."1.27[Combination chemotherapy of vincristine, ifosfamide and peplomycin in patients with reactivated prostatic cancer]. ( Akiya, T; Katayama, T; Kazama, T; Nakada, T; Umeda, K, 1986)

Research

Studies (47)

TimeframeStudies, this research(%)All Research%
pre-199015 (31.91)18.7374
1990's16 (34.04)18.2507
2000's11 (23.40)29.6817
2010's4 (8.51)24.3611
2020's1 (2.13)2.80

Authors

AuthorsStudies
Findlay, BL1
Gargollo, PC1
Granberg, CF1
Xing, PY1
Shi, YK1
Feng, FY1
Qin, Y1
Liu, P1
Uemura, K1
Nishihara, K1
Hayashi, T1
Tomiyasu, K1
Matsuoka, K1
Hervonen, P3
Tulijoki, T1
Kellokumpu-Lehtinen, P3
Latz, S1
Ellinger, J1
Goltz, D1
Marx, C1
Leuschner, I1
Müller, SC1
Fechner, G1
Lehtinen, T1
Tammela, TL1
Lam, KC1
Yeo, W1
Shirakawa, T1
Fujisawa, M1
Gotoh, A1
Okada, H1
Arakawa, S1
Kamidono, S1
Jekunen, A1
Lefebvre, P1
Watanabe, A1
Taniguchi, M1
Saito, T1
Kitamura, Y2
Komatsubara, S2
Kaku, H1
Saika, T2
Tsushima, T5
Nagai, A1
Yokoyama, T1
Abarzua, F1
Ebara, S1
Manabe, D1
Nasu, Y3
Kumon, H3
Csomor, J1
Kaszás, I1
Kollár, B1
Pajor, L1
Egyházi, Z1
Fekete, S1
Egyed, M1
Timár, B1
Kawai, T2
Takeda, T1
Kihara, K3
Sakuramoto, T1
Satomi, Y1
Akimoto, S1
Ohki, T1
Akakura, K1
Masai, M1
Shimazaki, J2
Watanabe, M1
Sakata, Y1
Ushiyama, T1
Ihara, H1
Kurita, Y1
Kageyama, S1
Ueda, D1
Mugiya, S1
Yamaguchi, Y1
Nakano, M2
Suzuki, K1
Kawabe, K1
Fujita, K1
Matsushima, H1
Kaneko, T1
Palmer, MA1
Viswanath, S1
Desmond, AD1
Stüben, J1
Port, R1
Bertram, B1
Bollow, U1
Hull, WE1
Schaper, M1
Pohl, J1
Wiessler, M2
Williamson, SK1
Wolf, MK1
Eisenberger, MA1
O'Rourke, MA1
Brannon, W1
Crawford, ED1
Ashraf, MS1
Skinner, R1
English, MW1
Craft, AW1
Pearson, AD1
Tsumatani, K1
Ozono, S1
Momose, H1
Hirao, Y1
Okajima, E1
Kaneko, Y1
Watanabe, S1
Samma, S1
Yamada, K1
Palackdharry, CS1
Haberkorn, U1
Krems, B1
Gerlach, L1
Bachert, P1
Morr, I1
van Kaick, G1
Maki, Y1
Ohmori, H2
Tanahashi, T2
Nanba, K2
Ohashi, T1
Kondo, K1
Asahi, T1
Saegusa, M2
Ozaki, Y3
Yamashita, Y1
Katayama, Y1
Kobuke, M1
Uno, S1
Ochi, J2
Kobashi, K1
Hata, K1
Kitsukawa, S1
Kinn, T1
Yoshida, T1
Yonese, J1
Izutami, T1
Fukui, I3
Ishikawa, Y1
Kondo, N1
Tomita, M1
Hasegawa, N1
Kazama, A1
De Raeve, H1
Jeuris, W1
Wyndaele, JJ1
Van Marck, E1
Miyanaga, N1
Tsukamoto, S1
Hattori, K1
Kawai, K1
Shimazui, T1
Uchida, K1
Akaza, H1
Maeda, O1
Saiki, S1
Kinouchi, T1
Kuroda, M1
Miki, T1
Usami, M1
Kotake, T1
Mahjoubi, M1
Azab, M1
Ghosn, M1
Theodore, C1
Droz, JP1
Yoshimoto, J2
Akagi, T2
Obama, T2
Matsumura, Y1
Fuse, H1
Ando, K1
Hara, S1
Zama, S1
Kazama, T1
Katayama, T1
Umeda, K1
Akiya, T1
Nakada, T1
Hara, M1
Moriyama-Gonda, N2
Kishi, H1
Himeno, Y1
Ishibe, T3
Mizutani, M1
Ehara, S1
Usui, T2
Nukui, M1
Nakao, M1
Nakagawa, S1
Toyoda, K1
Takada, H1
Ebisui, K1
Watanabe, H1
Miyakoda, K1
Kobayashi, T1
Fujiwara, M1
Nightingale, SL1
Dunzendorfer, U1
Takeuchi, S2
Higashi, Y2
Andoh, M1
Kitahara, S2
Horiuchi, S1
Oshima, H2
Tsukagoshi, S1
Negishi, T1
Hosoda, K1
Ikegami, S1
Moriyama, N1
Nagafuji, T1
Ohsumi, Y1
Brock, N1

Reviews

6 reviews available for ifosfamide and Prostatic Neoplasms

ArticleYear
[Clinical characteristics and treatment of desmoplastic small round cell tumor].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:2

    Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas

2010
[Combination chemotherapy with cis-platinum and ifosfamide for hormone unresponsive prostate cancer].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1998, Volume: 89, Issue:7

    Topics: Aged; Alopecia; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cis

1998
[Successful multidisciplinary treatment for bladder cancer with priapism. A case report].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1998, Volume: 89, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Comb

1998
[Chemotherapy for prostate cancer].
    Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58 Suppl

    Topics: Antineoplastic Agents; Cisplatin; Estramustine; Humans; Ifosfamide; Male; Peplomycin; Prostatic Neop

2000
Cystosarcoma phyllodes of the prostate with rhabdomyoblastic differentiation.
    Pathology, research and practice, 2001, Volume: 197, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Fatal

2001
[Chemotherapy and radiotherapy for urological cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Administrati

2002

Trials

11 trials available for ifosfamide and Prostatic Neoplasms

ArticleYear
No additional benefit of adding ifosfamide to docetaxel in castration-resistant metastatic prostate cancer.
    Anticancer research, 2012, Volume: 32, Issue:8

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Ifosfami

2012
A randomised dose-finding phase II study on ifosfamide in metastatic hormone-refractory prostate cancer (HRPC).
    Journal of experimental & clinical cancer research : CR, 2002, Volume: 21, Issue:2

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Alkylating; Bone Neoplasms; Disease Progression; Dose-R

2002
Docetaxel-ifosfamide combination chemotherapy in patients with metastatic hormone-refractory prostate cancer: a phase I pharmacokinetic study.
    International journal of clinical pharmacology research, 2003, Volume: 23, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Docetaxel; Humans; Ifosfamide; Mal

2003
Combination chemotherapy with estramustine phosphate, ifosfamide and cisplatin for hormone-refractory prostate cancer.
    Acta medica Okayama, 2006, Volume: 60, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Comb

2006
Chemotherapy for endocrine-therapy-refractory prostate cancer.
    Cancer chemotherapy and pharmacology, 1994, Volume: 35 Suppl

    Topics: Acid Phosphatase; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin

1994
[Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1993, Volume: 39, Issue:12

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Diethylstilbestrol; Drug Admin

1993
Phase II evaluation of ifosfamide/mesna in metastatic prostate cancer. A Southwest Oncology Group study.
    American journal of clinical oncology, 1996, Volume: 19, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; B

1996
[Clinical study of testicular cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1996, Volume: 42, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combi

1996
Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
    Seminars in oncology, 1997, Volume: 24, Issue:1 Suppl 2

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carci

1997
Phase II trial of ifosfamide in the treatment of metastatic hormone-refractory patients with prostatic cancer.
    Cancer investigation, 1990, Volume: 8, Issue:5

    Topics: Aged; Drug Administration Schedule; Humans; Ifosfamide; Male; Mesna; Middle Aged; Prostatic Neoplasm

1990
[A randomized trial of chemotherapy of advanced prostatic cancer with ifosfamide alone versus ifosfamide, 5-fluorouracil and cisplatin (preliminary report)].
    Nihon Gan Chiryo Gakkai shi, 1988, Oct-20, Volume: 23, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation;

1988

Other Studies

30 other studies available for ifosfamide and Prostatic Neoplasms

ArticleYear
Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Pediatric Sarcoma for Maximal Oncologic Control.
    Urology, 2020, Volume: 141

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Cystectomy; Cytoreducti

2020
Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Ifosfamide; Infusions, Intra-Arte

2012
Spindle cell rhabdomyosarcoma of the prostate.
    International journal of urology : official journal of the Japanese Urological Association, 2013, Volume: 20, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Magne

2013
Chemotherapy induced complete remission in malignant phyllodes tumor of the prostate metastasizing to the lung.
    The Journal of urology, 2002, Volume: 168, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Humans; Ifosfamide; Lung Neoplas

2002
Complete resection of synovial sarcoma of prostatic fascia.
    Urology, 2003, Volume: 61, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Humans; Ifosfam

2003
[A case of oropharyngeal cancer with multiple bone metastases from prostate cancer that responded to docetaxel, ifosfamide and cisplatin combination therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Cisp

2005
[Chemo-endocrine therapy for newly diagnosed stage D2 prostate cancer].
    Hinyokika kiyo. Acta urologica Japonica, 2005, Volume: 51, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etopo

2005
Prolonged survival using anti-CD20 combined chemotherapy in primary prostatic intravascular large B-cell lymphoma.
    Pathology oncology research : POR, 2008, Volume: 14, Issue:3

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineo

2008
[Treatment of pain caused by metastases of reactivated prostatic cancer with ifosfamide].
    Gan no rinsho. Japan journal of cancer clinics, 1983, Volume: 29, Issue:10

    Topics: Aged; Cyclophosphamide; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metast

1983
[Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1993, Volume: 39, Issue:2

    Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Aminopeptidases; Antineoplastic Combined Chemotherap

1993
[Ifosfamide in combined hormonochemotherapy on prostate cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone

1994
Adult prostatic rhabdomyosarcoma.
    British journal of urology, 1993, Volume: 71, Issue:4

    Topics: Adult; Combined Modality Therapy; Humans; Ifosfamide; Male; Prostatectomy; Prostatic Neoplasms; Rhab

1993
Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:4

    Topics: Animals; Antineoplastic Agents; Autoradiography; Bile; DNA, Neoplasm; Female; Glucose; Half-Life; Hu

1996
Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child.
    Medical and pediatric oncology, 1997, Volume: 28, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Child, Preschool; Chronic Disease; Fanconi Syndrome; Glomerular F

1997
Assessment of glucosylifosfamide mustard biodistribution in rats with prostate adenocarcinomas by means of in vivo 31P NMR and in vitro uptake experiments.
    Magnetic resonance in medicine, 1998, Volume: 39, Issue:5

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Drug Monitoring; Drug Screening Assays,

1998
[A case of metastatic liver tumors from prostatic cancer responding to intra-arterial infusion chemotherapy with CDDP and ifosfamide using implantable port].
    Hinyokika kiyo. Acta urologica Japonica, 1999, Volume: 45, Issue:6

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasm

1999
[Combination chemotherapy with ifosfamide (or cyclophosphamide), adriamycin, cis-platinum and peplomycin (IAPP) for hormonally resistant metastatic prostatic cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1991, Volume: 37, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Admini

1991
[Combination chemotherapy of vincristine, ifosfamide and peplomycin in patients with advanced stage D adenocarcinoma of the prostate].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1985, Volume: 76, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Evaluation; Humans;

1985
[Reactivation of prostatic cancer and chemotherapy in reactivated prostatic cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1985, Volume: 31, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Humans; Ifosfamid

1985
[Combination chemotherapy of vincristine, ifosfamide and peplomycin in patients with reactivated prostatic cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1986, Volume: 32, Issue:2

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Evaluation; Hu

1986
[Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:2

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug A

1987
[Inhibitory effect of various combinations of peplomycin, vincristine and ifosfamide against a hormone-independent human prostatic carcinoma cell line].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Division; Cell Line; Cell Survival;

1988
Inhibitory effects of vincristine, ifosfamide and peplomycin on hormone-independent human prostatic carcinoma cell line.
    Experimental pathology, 1988, Volume: 35, Issue:3

    Topics: Bleomycin; Cell Division; Cell Line; Drug Combinations; Humans; Ifosfamide; Male; Peplomycin; Prosta

1988
[Treatment of hormonal refractory adenocarcinoma of the prostate with ifosfamide (IFM) and the combination of vincristine ifosfamide and peplomycin (VIP)].
    Hinyokika kiyo. Acta urologica Japonica, 1989, Volume: 35, Issue:3

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin;

1989
From the Food and Drug Administration.
    JAMA, 1989, Apr-14, Volume: 261, Issue:14

    Topics: Acyclovir; Anilides; Cytomegalovirus Infections; Flutamide; Ganciclovir; Humans; Ifosfamide; Male; M

1989
Hormonal chemotherapy.
    Progress in clinical and biological research, 1989, Volume: 303

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diethylstilbestrol; Epiru

1989
[Combination chemotherapy with ifosfamide, 5-fluorouracil, cisplatin for stage D2 prostatic cancer].
    Hinyokika kiyo. Acta urologica Japonica, 1989, Volume: 35, Issue:9

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorouracil; Human

1989
[Ifomide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:1

    Topics: Animals; Bone Neoplasms; Carcinoma, Small Cell; Female; Humans; Ifosfamide; Leukemia, Experimental;

1987
[Study of anti-cancer chemotherapy of prostatic carcinoma. I. Comparative study of ifosfamide and VIP against a hormone-independent human prostatic carcinoma cell line].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cells, Cultured; Cisplatin; Humans; I

1987
Ideas and reality in the development of cancer chemotherapeutic agents, with particular reference to oxazaphosphorine cytostatics.
    Journal of cancer research and clinical oncology, 1986, Volume: 111, Issue:1

    Topics: Alkylating Agents; Antineoplastic Agents; Biotransformation; Cyclophosphamide; Female; Humans; Ifosf

1986